AI News, GNS Healthcare News & Events: Healthcare Analytics & Causal ... artificial intelligence

GNS Healthcare Raises $23 Million Led by Cigna Ventures

CAMBRIDGE, Mass., July 9, 2019 /PRNewswire/ -- GNS Healthcare (GNS), a leading precision medicine company, today announced a $23 million Series D fundraising round, led by Cigna Ventures, a strategic corporate venture capital partner and wholly owned indirect subsidiary of Cigna Corporation (NYSE: CI). Joining the Cigna Ventures-led funding round were Amgen Ventures, Celgene, Echo Health Ventures, Alexandria Venture Investments, as well as former Caesar's CEO and Aetna Division President Gary Loveman.

said Colin Hill, Chairman, CEO and Co-Founder of GNS Healthcare. "As one of the largest and most forward-thinking global health services companies, Cigna is the perfect complement to our cadre of leading biopharma companies and health plan partners committed to improving patient outcomes through causal AI and the precision healthcare it enables."

GNS's causal AI technology transforms data streams into in silico patients that precisely match therapeutics, procedures and care management interventions to individuals to drive personalized clinical care and medicine and improve health outcomes.

"GNS aligns with our vision and together we can super-charge our advanced analytics capabilities and provide even deeper, more predictable insights that will further enhance customer access to the highest quality treatment and care, in the preferred and appropriate place, at the right time."

Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits, and other related products including group life, accident and disability insurance.

Cigna Ventures leads $23M funding round in precision medicine company GNS Healthcare

Cigna Ventures joins other big names in health insurance and biotech backing GNS Healthcare, a technology company that uses machine learning to provide precision medicine.

GNS uses machine learning to effectively match the appropriate therapeutics, procedures and treatment intervention to the right patient at the right time. Cigna Ventures plans to tap GNS’ technology and solutions to further advance whole-person health for Cigna’s customers and clients, the company said.

RELATED: Cigna closes $67B Express Scripts acquisition, promising affordability and choice “Cigna is committed to improving the total health and well-being of our customers—and the personalized clinical care interventions that we expect GNS to facilitate will play a huge role in achieving those improvements,” Tom Richards, senior vice president and global lead for strategy and business development at Cigna, said in a statement.

“GNS aligns with our vision and together we can super-charge our advanced analytics capabilities and provide even deeper, more predictable insights that will further enhance customer access to the highest quality treatment and care, in the preferred and appropriate place, at the right time.” Cigna Ventures launched in September 2018 and is focused on investing in three specific areas of healthcare, Richards told FierceHealthcare.

RELATED: Cigna's strong financial start to 2019 backed by Express Scripts acquisition Cigna’s initial focus will work to improve predictability and personalized treatment regimens, drive better outcomes and reduce the total cost of care for clients and customers.

GNS Healthcare Raises $23M in Series D Funding

Led by Colin Hill, Chairman, CEO and Co-Founder, GNS Healthcare aims to solve healthcare’s matching problem for health plans, biopharma companies, and health systems transforming massive and diverse data streams to precisely match therapeutics, procedures, and care management interventions to individuals. The

GNS causal learning and simulation platform, REFS, analyzes data sets beyond correlation, instead inferring causal mechanisms between variables to answer questions such as: How will the patient respond to this treatment?

Reimagine Healthcare | HIMSS 2019

The power of the cloud gives the ability to bring all the different data sources together to understand a patient's wellness and health better. At the HIMSS 2019 ...